Vhsquared Limited
Private Limited Company · London
Creditors Voluntary Liquidation (CVL)United KingdomIncorporated 2010Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2020-12-30
IXBRL · 153 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2020-12-30
IXBRL · 153 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2019-12-31 to 2020-12-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 105
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0088_07286540_20201230
- Source archive
- Accounts_Monthly_Data-March2021.zip
Accounts to 2010-11-30
XBRL · 22 source facts · 2 selected values
Not assessedlegacy record
Accounts to 2010-11-30
XBRL · 22 source facts · 2 selected values
Not assessed
legacy record
- Reporting period
- — to —
- Extraction status
- Legacy / not assessed
- Numeric facts
- 9
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-ae-2008-04-06.xsd
- Currency
- GBP
- Source identifier
- Prod224_9961_07286540_20101130
- Source archive
- Accounts_Monthly_Data-December2010.zip
Registered details
07286540- Status
- Liquidation
- Type
- Private Limited Company
- Incorporated
- 2010-06-16
- Jurisdiction
- —
- Registered office
- 4TH FLOOR, 95 GRESHAM STREET, LONDON, EC2V 7AB
Classification
1 SIC codes23105
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsReducing Risk on the clinical pathway to PoC for a novel oral biologic for IBDLead
Innovate UK · Collaborative R&D · 2015-05-01 – 2016-07-31
£1,228,128
awarded
Formulation Feasibility: The Optimal Dosage Form For An Oral Domain AntibodyLead
Innovate UK · Feasibility Studies · 2013-12-01 – 2014-08-31
£59,953
awarded
Market assessment for innovative functional food productsLead
Innovate UK · GRD Proof of Market · 2012-01-01 – 2012-06-30
£25,000
awarded
Manufacture of high value antibodies for functional foodsLead
Innovate UK · Collaborative R&D · 2011-07-01 – 2012-03-31
£100,000
awarded